Should deep-sequenced amplicons become the new gold-standard for analysing malaria drug clinical trials? (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.5451/unibas-ep89093
Publication URI: https://edoc.unibas.ch/89093/
Type: Other